Publications
150
Citations
5,327
Est. group size
~2
Recurring co-author estimate
Active years
37
Publishing since 1990
Susan L. Koletar's research focuses on the long-term health effects of HIV infection and its treatment, including cardiovascular disease, kidney disease, bone health, frailty, and cognitive function in people living with HIV, especially as they age. Her work also spans clinical trials of new HIV treatments and vaccines, and studies of screening and care access for HIV-related conditions like cancer. This research draws heavily on large multi-site cohort studies and multicenter clinical trials involving people with HIV.
Publication output has been fairly steady over the past decade with a notable increase in output from 2023 onward compared to a mid-decade dip around 2021-2022.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
The Lancet HIV · 2026
- P-351. Mastering HIV: The Full Spectrum of Training During ID Fellowship
Open Forum Infectious Diseases · 2026
- P-236. The Effect of Hospitalization on Neurocognitive Function in People with HIV
Open Forum Infectious Diseases · 2026
- Serum Biomarkers of Macrophage Activation and Incident CKD in People With and Without HIV: Findings From the MACS-WIHS Combined Cohort Study
Open Forum Infectious Diseases · 2026
- Serum Biomarkers of Macrophage Activation and Incident CKD in People With and Without HIV: Findings From the MACS-WIHS Combined Cohort Study.
UNC Libraries · 2026
- Low serum testosterone concentrations predict incident frailty in men with HIV
The Journal of Clinical Endocrinology & Metabolism · 2026
- Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
JCI Insight · 2025
- No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
AIDS · 2025
- Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357
Clinical Infectious Diseases · 2025
- HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine
JAMA · 2025
- Glycation metabolites predict incident age-related comorbidities and mortality in older people with HIV
GeroScience · 2025
- P-495. Anal Cancer Screening and Referral Practices in an Academic Medical Center Affiliated HIV Clinic in Columbus, Ohio
Open Forum Infectious Diseases · 2025
- P-439. Breast Cancer (BC) and Colorectal Cancer (CRC) Screenings among Persons with HIV (PWH): The Role of Individual and System-Level Factors on Screening Completion
Open Forum Infectious Diseases · 2025
- SAT-730 Evaluating the Association Between Bone Metabolism Markers and Bone Mineral Density in Men with and without HIV
Journal of the Endocrine Society · 2025
- HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse
JAMA · 2024
- Open Forum Infectious Diseases×15
- Clinical Infectious Diseases×10
- AIDS×8
- JAMA Network Open×6
- UNC Libraries×6
- B Peters
Medicine · Purdue University West Lafayette
- Jean-Guy Baril
Medicine · Indiana University
- Nicholas Funderburg
Medicine · The Ohio State University
- Samir K. Gupta
Medicine · Indiana University
- Emily Bowman
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile